Skip to main content
. 2021 Apr 8;60(7):835–853. doi: 10.1007/s40262-021-01005-1

Fig. 4.

Fig. 4

DDI profiles of oral cabotegravir and rilpivirine or intramuscular cabotegravir plus rilpivirine when considering non-HIV co-medications (n = 725) listed in the University of Liverpool HIV drug interaction website [68]. DDI drug–drug interaction